Concepedia

Hiroko Tonai‐Kachi

HT

8

Publications

448

Citations

8

H-Index

2002

Active since

Affiliations

Pfizer (Japan)(Current)

Pfizer (United States)

Hiroko Tonai‐Kachi is an author at Pfizer (Japan) specializing in medicine, physiology, and pharmacology.

Top concepts

Publications per year

2002–2008

8

Publications

8

Zaprinast, a well‐known cyclic guanosine monophosphate‐specific phosphodiesterase inhibitor, is an agonist for GPR35

Yasuhito Taniguchi, Hiroko Tonai‐Kachi, Katsuhiro Shinjo · FEBS Letters · 2006 · 149 citations

GPR35 is a functional receptor in rat dorsal root ganglion neurons

Hiroyuki Ohshiro, Hiroko Tonai‐Kachi, Katsuomi Ichikawa · Biochemical and Biophysical Research Communications · 2007 · 103 citations

, , +9

Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation

Akio Murase, Takako Okumura, Ayano Sakakibara et al. · European Journal of Pharmacology · 2007 · 56 citations

, , +10

In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP4 receptor antagonist

Akio Murase, Yasuhito Taniguchi, Hiroko Tonai‐Kachi et al. · Life Sciences · 2007 · 48 citations

, , +7

5-Nitro-2-(3-Phenylpropylamino)benzoic Acid Is a GPR35 Agonist

Yasuhito Taniguchi, Hiroko Tonai‐Kachi, Katsuhiro Shinjo · Pharmacology · 2008 · 30 citations

Rows per page

1–5 of 8